Systematic review: Are lymphocytic colitis and collagenous colitis two subtypes of the same disease - Microscopic colitis?

Alimentary Pharmacology and Therapeutics

Volumn 36, Issue 2, 2012, Pages 79-90

  Rasmussen, M A ^a   Munck, L K ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KØGE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTON PUMP INHIBITOR;

BILE ACID DIARRHEA; CELIAC DISEASE; CLINICAL FEATURE; COLLAGENOUS COLITIS; COMORBIDITY; DIABETES MELLITUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DRUG USE; ENDOSCOPY; FOLLOW UP; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTIC COLITIS; MICROSCOPIC COLITIS; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SEX DIFFERENCE; SYSTEMATIC REVIEW;

ANTI-INFLAMMATORY AGENTS; BUDESONIDE; COLITIS, COLLAGENOUS; COLITIS, LYMPHOCYTIC; COLITIS, MICROSCOPIC; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 84862574060     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2012.05166.x     Document Type: Review

References (77)

1. Pardi SP, Kelly CP,. Microscopic colitis. Gastroenterology 2011; 140: 1155-65.
2. Temmerman F, Baert F,. Collagenous and lymphocytic colitis: systematic review and update of the literature. Dig Dis Sci 2009; 27: 137-45.
3. Lazenby AJ, Yardley JH, Giardiello FM, et al,. Lymphocytic ("microscopic") colitis: a comparative histopathologic study with particular reference to collagenous colitis. Hum Pathol 1989; 20: 18-28. (Pubitemid 19041991)
4. Lindstrøm C,. "Collagenous colitis" with watery diarrhoea -a new entity? Pathol Eur 1976; 11: 87-9.
5. Lazenby A,. Collagenous and lymphocytic colitis. Semin Diagn Pathol 2005; 22: 295-300. (Pubitemid 44118643)
6. Baert F, Wouters K, D'Haens G, et al,. Lymphocytic colitis: a distinct clinical entity? A clinicopathological confrontation of lymphocytic and collagenous colitis. Gut 1999; 45: 375-81. (Pubitemid 29400713)
7. Fraser AG, Warren BF, Chandrapala R, et al,. Microscopic colitis: a clinical and pathological review. Scand J Gastroenterol 2002; 37: 1241-5. (Pubitemid 35305758)
8. Bjørnbak C, Engel PJH, Nielsen PL, et al,. Microscopic colitis: clinical findings, topography and persistence of histopathological subgroups. Aliment Pharmacol Ther 2011; 34: 1225-34.
9. Mullhaupt B, Güller U, Anabitarte M, et al,. Lymphocytic colitis: clinical presentation and long term course. Gut 1998; 43: 629-33. (Pubitemid 28520095)
10. Tysk C, Bohr J, Nyhlin N, et al,. Diagnosis and management of microscopic colitis. World J Gastroenterol 2008; 14: 7280-8.
11. Fernández-Bañares F, Salas A, Esteve M, et al,. Evolution of the incidence of collagenous colitis and lymphocytic colitis in Terrassa, Spain: a population-based study. Inflamm Bowel Dis 2011; 17: 1015-20.
12. Fernández-Bañares F, Salas A, Forné M, et al,. Incidence of collagenous and lymphocytic colitis: a 5-year population-based study. Am J Gastroenterol 1999; 94: 418-23. (Pubitemid 29084662)
13. Guagnozzi D, Lucendo AJ, Angueira-Lapeña T, et al,. Prevalence and incidence of microscopic colitis in patients with diarrhoea of unknown aetiology in a region in central Spain. Dig Liver Dis 2012; 44: 384-8.
14. Chande N, MacDonald JK, McDonald JWD,. Interventions for treating microscopic colitis: a Cochrane Inflammatory Bowel Disease and Functional Bowel Disorders Review Group systematic review of randomized trials. Am J Gastroenterol 2009; 104: 235-41.
15. Tysk C, Wickbom A, Nyhlin N, et al,. Recent advances in diagnosis and treatment of microscopic colitis. Ann Gastroenterol Hepatol 2011; 24: 253-62.
16. Yen EF, Pardi DS,. Review article: microscopic colitis-lymphocytic, collagenous and "mast cell" colitis. Aliment Pharmacol Ther 2011; 34: 21-32.
17. Veress B, Ulfberg R, Bergman L,. Microscopic colitis syndrome. Gut 1995; 36: 880-6.
18. Stewart MJ, Seow CH, Storr M,. Prednisolone and budesonide for short- and long-term treatment of microscopic colitis: systematic review and meta-analysis. Clin Gastroenterol Hepatol 2011; 9: 881-90.
19. Olesen M, Eriksson S, Bohr J, et al,. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Örebro, Sweden, 1993-1998. Gut 2004; 53: 346-50. (Pubitemid 38241327)
20. Pardi DS, Loftus EV Jr, Smyrk TC, et al,. The epidemiology of microscopic colitis: a population based study in Olmsted County, Minnesota. Gut 2007; 56: 504-9.
21. Stewart M, Andrews CN, Urbanski S, et al,. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther 2011; 33: 1340-9.
22. Kitchen PA, Levi AJ, Domizio P, et al,. Microscopic colitis: the tip of the iceberg? Eur J Gastroenterol Hepatol 2002; 14: 1199-204. (Pubitemid 35471528)
23. Fernández-Bañares F, Casalots J, Salas A, et al,. Paucicellular lymphocytic colitis: is it a minor form of lymphocytic colitis? A clinical pathological and immunological study. Am J Gastroenterol 2009; 104: 1189-98.
24. Shaz BH, Reddy SI, Ayata G, et al,. Sequential clinical and histopathological changes in collagenous and lymphocytic colitis over time. Mod Pathol 2004; 17: 395-401. (Pubitemid 41646593)
25. Bonner GF, Petras RE, Cheong DM, et al,. Short- and long-term follow-up of treatment for lymphocytic and collagenous colitis. Inflamm Bowel Dis 2000; 6: 85-91.
26. Olesen M, Eriksson S, Bohr J, et al,. Lymphocytic colitis: a retrospective clinical study of 199 Swedish patients. Gut 2004; 53: 536-41. (Pubitemid 38372978)
27. Limsui D, Pardi DS, Smyrk TC, et al,. Observer variability in the histologic diagnosis of microscopic colitis. Inflamm Bowel Dis 2009; 15: 35-8.
28. Koskela RM, Niemelä SE, Karttunen TJ, et al,. Clinical characteristics of collagenous and lymphocytic colitis. Scand J Gastroenterol 2004; 39: 837-45. (Pubitemid 39215454)
29. Fernández-Bañares F, Esteve M, Espinõs JC, et al,. Drug consumption and the risk of microscopic colitis. Am J Gastroenterol 2007; 102: 324-30. (Pubitemid 46160546)
30. Pascua MF, Kedia P, Weiner MG, et al,. Microscopic colitis and medication use. Gastroenterology 2010; 3: 11-9.
31. Keszthelyi D, Jansen SV, Schouten GA, et al,. Proton pump inhibitor use is associated with an increased risk for microscopic colitis: a case-control study. Aliment Pharmacol Ther 2010; 32: 1124-8.
32. Yen EF, Pokhrel B, Du H, et al,. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis 2011; 6: 1-7.
33. Vigren L, Sjöberg K, Benoni C, et al,. Is smoking a risk factor for collagenous colitis? Scand J Gastroenterol 2011; 46: 1334-9.
34. Fernandez-Bañares F, Esteve M, Salas A, et al,. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci 2001; 46: 2231-8. (Pubitemid 32955237)
35. Fernandez-Bañares F, Salas A, Esteve M, et al,. Collagenous and lymphocytic colitis: evaluation of clinical and histological features, response to treatment, and long-term follow-up. Am J Gastroenterol 2003; 98: 340-7. (Pubitemid 36232383)
36. Giardiello FM, Lazenby AJ, Bayless TM, et al,. Lymphocytic (microscopic) colitis. Clinicopathologic study of 18 patients and comparison to collagenous colitis. Dig Dis Sci 1989; 34: 1730-8. (Pubitemid 19275334)
37. Gu H, Zhi F, Huang Y,. Microscopic colitis in patients with chronic diarrhea and normal colonoscopic findings in Southern China. Int J Colorectal Dis 2012 [Epub ahead of print].
38. Kao KT, Pedraza BA, McClune A, et al,. Microscopic colitis: a large retrospective analysis from a health maintenance organization experience. World J Gastroenterol 2009; 15: 3122-7.
39. Holstein A, Burmeister J, Plaschke A, et al,. Antibody profiles in microscopic colitis. J Gastroenterol Hepatol 2006; 21: 1016-20.
40. Williams JJ, Kaplan GG, Makhija S, et al,. Microscopic colitis-defining incidence rates and risk factors: a population-based study. Clin Gastroenterol Hepatol 2008; 6: 35-40. (Pubitemid 350309538)
41. Thörn M, Sjöberg D, Ekbom A, et al,. Microscopic colitis-a population-based study from Uppsala health region in Sweden. J Crohns Colitis 2012; 6 (Suppl. 1): A405.
42. Ung K, Gillberg R, Kilander A, et al,. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut 2000; 46: 170-5. (Pubitemid 30305841)
43. Sapp H, Ithamukkala S, Brien TP, et al,. The terminal ileum is affected in patients with lymphocytic or collagenous colitis. Am J Surg Pathol 2002; 26: 1484-92. (Pubitemid 35239425)
44. Moayyedi P, O'Mahony S, Jackson P, et al,. Small intestine in lymphocytic and collagenous colitis: mucosal morphology, permeability, and secretory immunity to gliadin. J Clin Pathol 1997; 50: 527-9. (Pubitemid 27316005)
45. Padmanabhan V, Callas PW, Li SC,. Histopathological features of the terminal ileum in lymphocytic and collagenous colitis: a study of 32 cases and review of literature. Mod Pathol 2003; 16: 115-9. (Pubitemid 36245742)
46. Ung K, Kilander A, Willéen R, et al,. Role of bile acids in lymphocytic colitis. Hepatogastroenterology 2002; 49: 432-7. (Pubitemid 34606568)
47. Baert D, Coppens M, Burvenich P, et al,. Chronic diarrhoea in non collagenous microscopic colitis: therapeutic effect of cholestyramine. Acta Clin Belg 2004; 59: 258-62. (Pubitemid 40029483)
48. Rampton DS, Baithun SI,. Is microscopic colitis due to bile-salt malabsorption? Dis Colon Rectum 1987; 30: 950-2. (Pubitemid 18018810)
49. Calabrese C, Gionchetti P, Liguori G,. Clinical course of microscopic colitis in a single-center cohort study. J Crohns Colitis 2011; 5: 218-21.
50. Baert F, Schmit A, D'Haens G, et al,. Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-up. Gastroenterology 2002; 122: 20-5. (Pubitemid 34049190)
51. Miehlke S, Madisch A, Karimi D, et al,. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study. Gastroenterology 2009; 136: 2092-100.
52. Mosnier j, Larvol L, Barge J, et al,. Lymphocytic and collagenous colitisi: an immunihistochemical study. Am J Gastroenterol 1996; 91: 709-13. (Pubitemid 126733806)
53. Protic M, Jojic N, Bojic D, et al,. Mechanism of diarrhea in microscopic colitis. World J Gastroenterol 2005; 11: 5535-9. (Pubitemid 41684715)
54. Bürgel N, Boiarski C, Mankertz J, et al,. Mechanisms of diarrhea in collagenous colitis. Gastroenterology 2002; 123: 433-43. (Pubitemid 34827187)
55. Bohr J, Järnerot G, Tysk C, et al,. Effect of fasting on diarrhoea in collagenous colitis. Digestion 2002; 65: 30-4. (Pubitemid 34310041)
56. Jensen J, Munck LK,. Elementary diet eliminates diarrhoea in patients with severe collagenous diarrhoea of long duration. Scand J Gastroenterol 2005; 40: 1495-6.
57. Järnerot G, Tysk C, Bohr J, et al,. Collagenous colitis and fecal stream diversion. Gastroenterology 1995; 109: 449-55.
58. Bajor A, Kilander A, Gälman C, et al,. Budesonide treatment is associated with increased bile acid absorption in collagenous colitis. Aliment Pharmacol Ther 2006; 24: 1643-9. (Pubitemid 44915212)
59. Riddell RH, Tanaka M, Mazzoleni G,. Non-steroidal anti-inflammatory drugs as a possible cause of collagenous colitis: a case-control study. Gut 1992; 33: 683-6.
60. Wang N, Dumot J, Achkar E, et al,. Colonic epithelial lymphocytosis without a thickened subepithelial collagen table: a clinicopathologic study of 40 cases supporting a heterogeneous entity. Am J Surg Pathol 1999; 23: 1068-74. (Pubitemid 29409768)
61. Bohr J, Tysk C, Eriksson S, et al,. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut 1996; 39: 846-51. (Pubitemid 27049088)
62. Abdo A, Raboud J, Freeman HJ, et al,. Clinical and histological predictors of response to medical therapy in collagenous colitis. Am J Gastroenterol 2002; 97: 1164-8. (Pubitemid 34478116)
63. Chande N, Driman DK, Reynolds RPE,. Collagenous colitis and lymphocytic colitis: patient characteristics and clinical presentation. Scand J Gastroenterol 2005; 40: 343-7. (Pubitemid 40476466)
64. Simondi D, Pellicano R, Reggiani S, et al,. A retrospective study on a cohort of patients with lymphocytic colitis. Rev Esp Enferm Dig 2010; 102: 381-4.
65. Sveinsson OA, Orvar KB, Birgisson S, et al,. Clinical features of microscopic colitis in a nation-wide follow-up study in Iceland. Scand J Gastroenterol 2008; 43: 955-60.
66. Pardi DS, Ramnath VR, Loftus EV Jr, et al,. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol 2002; 97: 2-6.
67. Goldstein N, Bhanot P,. Paucicellular and asymptomatic lymphocytic colitis. Am J Clin Pathol 2004; 122: 405-11.
68. Goff JS, Barnett JL, Pelke T, et al,. Collagenous colitis: histopathology and clinical course. Am J Gastroenterol 1997; 92: 57-60. (Pubitemid 27027029)
69. Jobse P, Flens MJ, Loffeld RJLF,. Collagenous colitis: description of a single centre series of 83 patients. Eur J Intern Med 2009; 20: 499-502.
70. Gillett HR, Freeman HJ,. Prevalence of celiac disease in collagenous and lymphocytic colitis. Can J Gastroenterol 2000; 14: 919-21. (Pubitemid 32103392)
71. Ung KA, Kilander A, Nilsson O, et al,. Long-term course in collagenous colitis and the impact of bile acid malabsorption and bile acid sequestrants on histopathology and clinical features. Scand J Gastroenterol 2001; 6: 601-9. (Pubitemid 32424251)
72. Nielsen H, Engel P, Munck LK,. Characteristics and long term clinical course of patients with collagenous and lymphocytic colitis. Gut 2005; 54: A172.
73. Agnarsdottir M, Gunnlaugsson O, Orvar K, et al,. Collagenous and lymphocytic colitis in Iceland. Dig Dis Sci 2002; 47: 1122-8. (Pubitemid 34439192)
74. Bohr J, Tysk C, Eriksson S, et al,. Collagenous colitis in Orebro, Sweden, an epidemiological study 1984-1993. Gut 1995; 37: 394-7.
75. Wickbom A, Nyhlin N, Eriksson S, et al,. Collagenous colitis and lymphocytic colitis in Örebro, Sweden 1999-2004; a continuous epidemiological study. Gut 2006; 55 (Suppl. V): A111.
76. Rajan J, Noble C, Anderson C, et al,. The epidemiology and clinical features of collagenous colitis in Lothian. Gut 2005; 54 (Suppl. 2): A99.
77. Heron T, Walsh S, Mowat A,. Microscopic colitis in Tayside: clinical features, associations, and behavior. Gut 2005; 54 (Suppl. 2): A84.